CY2020A - Alicyclic phospholipase A2 inhibitors - Google Patents
Alicyclic phospholipase A2 inhibitorsInfo
- Publication number
- CY2020A CY2020A CY202098A CY202098A CY2020A CY 2020 A CY2020 A CY 2020A CY 202098 A CY202098 A CY 202098A CY 202098 A CY202098 A CY 202098A CY 2020 A CY2020 A CY 2020A
- Authority
- CY
- Cyprus
- Prior art keywords
- inhibitors
- phospholipase
- alicyclic
- pla2
- certain novel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
- C07C63/66—Polycyclic acids with unsaturation outside the aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/612—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
- C07C69/618—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety having unsaturation outside the six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/62—Halogen-containing esters
- C07C69/65—Halogen-containing esters of unsaturated acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/734—Ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
- C07C69/94—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of polycyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
- C07C2603/24—Anthracenes; Hydrogenated anthracenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
- C07C2603/74—Adamantanes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Pain & Pain Management (AREA)
- Animal Behavior & Ethology (AREA)
- Rheumatology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7907293A | 1993-06-16 | 1993-06-16 | |
US08/200,798 US5436369A (en) | 1993-06-16 | 1994-02-23 | Alicyclic phospholipase A2 inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
CY2020A true CY2020A (en) | 1998-02-20 |
Family
ID=26761593
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY202098A CY2020A (en) | 1993-06-16 | 1998-02-20 | Alicyclic phospholipase A2 inhibitors |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP0629604B1 (xx) |
JP (1) | JPH0717913A (xx) |
CN (1) | CN1099380A (xx) |
AT (1) | ATE151742T1 (xx) |
AU (1) | AU667777B2 (xx) |
CA (1) | CA2125802A1 (xx) |
CY (1) | CY2020A (xx) |
CZ (1) | CZ288786B6 (xx) |
DE (1) | DE69402613T2 (xx) |
DK (1) | DK0629604T3 (xx) |
ES (1) | ES2102776T3 (xx) |
FI (1) | FI942796A (xx) |
GR (1) | GR3024104T3 (xx) |
HK (1) | HK116797A (xx) |
HU (1) | HU222521B1 (xx) |
IL (1) | IL110013A (xx) |
NO (1) | NO301417B1 (xx) |
NZ (1) | NZ260735A (xx) |
PL (1) | PL176790B1 (xx) |
SG (1) | SG50539A1 (xx) |
TW (1) | TW419461B (xx) |
ZA (1) | ZA944227B (xx) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1764405A1 (en) * | 2005-09-20 | 2007-03-21 | Rolic AG | Functionalized photoreactive compounds |
RU2453536C2 (ru) * | 2007-10-22 | 2012-06-20 | Оркид Рисерч Лабораториз Лимитед | Ингибиторы гистондезацетилазы |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CS244440B2 (en) * | 1983-02-28 | 1986-07-17 | Celamerck Gmbh & Co Kg | Method of acrylic acids' new amides production |
-
1994
- 1994-04-26 TW TW083103765A patent/TW419461B/zh not_active IP Right Cessation
- 1994-06-13 FI FI942796A patent/FI942796A/fi unknown
- 1994-06-13 NZ NZ260735A patent/NZ260735A/en unknown
- 1994-06-14 AU AU64666/94A patent/AU667777B2/en not_active Ceased
- 1994-06-14 JP JP6131532A patent/JPH0717913A/ja active Pending
- 1994-06-14 CA CA002125802A patent/CA2125802A1/en not_active Abandoned
- 1994-06-14 IL IL11001394A patent/IL110013A/en not_active IP Right Cessation
- 1994-06-15 CN CN94106460A patent/CN1099380A/zh active Pending
- 1994-06-15 DE DE69402613T patent/DE69402613T2/de not_active Expired - Fee Related
- 1994-06-15 AT AT94304337T patent/ATE151742T1/de not_active IP Right Cessation
- 1994-06-15 HU HU9401789A patent/HU222521B1/hu not_active IP Right Cessation
- 1994-06-15 SG SG1996004394A patent/SG50539A1/en unknown
- 1994-06-15 ES ES94304337T patent/ES2102776T3/es not_active Expired - Lifetime
- 1994-06-15 EP EP94304337A patent/EP0629604B1/en not_active Expired - Lifetime
- 1994-06-15 NO NO942244A patent/NO301417B1/no unknown
- 1994-06-15 DK DK94304337.2T patent/DK0629604T3/da active
- 1994-06-15 CZ CZ19941472A patent/CZ288786B6/cs not_active IP Right Cessation
- 1994-06-15 ZA ZA944227A patent/ZA944227B/xx unknown
- 1994-06-16 PL PL94303862A patent/PL176790B1/pl unknown
-
1997
- 1997-06-26 HK HK116797A patent/HK116797A/xx not_active IP Right Cessation
- 1997-07-15 GR GR970401755T patent/GR3024104T3/el unknown
-
1998
- 1998-02-20 CY CY202098A patent/CY2020A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
SG50539A1 (en) | 1998-07-20 |
CN1099380A (zh) | 1995-03-01 |
IL110013A0 (en) | 1994-10-07 |
IL110013A (en) | 1998-07-15 |
HU9401789D0 (en) | 1994-09-28 |
TW419461B (en) | 2001-01-21 |
HUT70550A (en) | 1995-10-30 |
PL176790B1 (pl) | 1999-07-30 |
AU667777B2 (en) | 1996-04-04 |
CZ288786B6 (cs) | 2001-09-12 |
EP0629604A3 (en) | 1995-03-01 |
ES2102776T3 (es) | 1997-08-01 |
PL303862A1 (en) | 1994-12-27 |
NO301417B1 (no) | 1997-10-27 |
JPH0717913A (ja) | 1995-01-20 |
HK116797A (en) | 1997-09-05 |
HU222521B1 (hu) | 2003-08-28 |
ATE151742T1 (de) | 1997-05-15 |
AU6466694A (en) | 1994-12-22 |
ZA944227B (en) | 1995-02-10 |
EP0629604B1 (en) | 1997-04-16 |
NZ260735A (en) | 1996-12-20 |
NO942244D0 (no) | 1994-06-15 |
DK0629604T3 (da) | 1997-09-15 |
EP0629604A2 (en) | 1994-12-21 |
NO942244L (no) | 1994-12-19 |
FI942796A0 (fi) | 1994-06-13 |
CA2125802A1 (en) | 1994-12-17 |
FI942796A (fi) | 1994-12-17 |
CZ147294A3 (en) | 1995-01-18 |
GR3024104T3 (en) | 1997-10-31 |
DE69402613T2 (de) | 1997-10-30 |
DE69402613D1 (de) | 1997-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2191492A (en) | Novel phospholipase a2 inhibitors | |
AU7015294A (en) | Hydrolytically stable pentaerythritol diphosphites | |
IL122266A0 (en) | Inhibitors of phospholipase A2 | |
ATE170867T1 (de) | Immunsuppressive aminomethylen-peptide | |
EP1130087A3 (en) | A method to identify compounds that alter the apoptotic process | |
AU658296B2 (en) | 7 beta-substituted-4-aza-5 alpha-cholestan-3-ones as 5 alpha-reductase inhibitors | |
MX9401175A (es) | Inhibidores de la acetilcolinesterasa sililada. | |
AU1545288A (en) | Phospholipase a2 inhibitors | |
AU2927489A (en) | Phospholipase a2 inhibitors | |
GR3024104T3 (en) | Alicyclic phospholipase A2 inhibitors. | |
AU8057394A (en) | An apparatus for disinfecting contact lenses | |
GR1002598B (el) | Παραγωγα επι-επιβατιδινης. | |
EP0838065A4 (en) | OPTICAL SYSTEM WITH SUBDIVISED FIELD FOR LOCATING MULTIPLE COMPONENTS | |
AU3587093A (en) | Hydrolytically stable pentaerythritol diphosphites | |
GB9323601D0 (en) | Plasma light source | |
GB2284091B (en) | Plasma light source | |
AU7459396A (en) | Preparation of aryl and vinyl nitriles | |
BR1100175A (pt) | Inibidores alicìclicos de fosfolipase a2 | |
AU662224B2 (en) | New 7beta-substituted-4-aza-5alpha-androstan-3-ones as 5alpha-reductase inhibitors | |
KR940027594U (ko) | 이온주입기의 이온소오스 생성장치 | |
DE59602769D1 (de) | Ionenquelle | |
TW381805U (en) | Shielding device for the source chamber of ion implantion machine | |
GB9301545D0 (en) | Light source | |
GB9302159D0 (en) | Light source |